APA (7th ed.) Citation

Geis, N., Zell, S., Rutz, R., Li, W., Giese, T., Mamidi, S., . . . Kirschfink, M. (2010). Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. Current cancer drug targets, 10(8), . https://doi.org/10.2174/156800910793357952

Chicago Style (17th ed.) Citation

Geis, Nicolas, Stefanie Zell, Renate Rutz, Wenhan Li, Thomas Giese, Srinivas Mamidi, Stefan Schultz, and Michael Kirschfink. "Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by SiRNA Sensitizes Tumor Cells to Complement Attack in Vitro." Current Cancer Drug Targets 10, no. 8 (2010). https://doi.org/10.2174/156800910793357952.

MLA (9th ed.) Citation

Geis, Nicolas, et al. "Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by SiRNA Sensitizes Tumor Cells to Complement Attack in Vitro." Current Cancer Drug Targets, vol. 10, no. 8, 2010, https://doi.org/10.2174/156800910793357952.